Publications by authors named "Werner Bachmann"
Background: Survey by the commission for cross-sectoral ophthalmology, as a joint commission of the German Ophthalmological Society (DOG) and the Professional Association of German Ophthalmologists (BVA) on the effects of the SARS-CoV‑2 pandemic on ophthalmological patient care in Germany.
Methods: Online-based survey.
Results: A total of 1190 questionnaires were (partly) answered.
Background: Survey by the commission for cross-sectoral ophthalmology, as a joint commission of the German Ophthalmological Society (DOG) and the Professional Association of German Ophthalmologists (BVA) on the effects of the SARS-CoV‑2 pandemic on ophthalmological patient care in Germany.
Methods: Online-based survey.
Results: A total of 1190 questionnaires were (partly) answered.
Background: Despite the liberalization of the Therapeutic Products Advertising Act, advertising that praises, misleads or compares is still contrary to the German professional conduct. In view of the increasing commitment of financial investors and the economization in ophthalmology, this study was initiated to examine and check which (advertising) statements are affected in openly accessible videos on the YouTube platform.
Methods: Using the search terms "ophthalmologist" and "eye center" as well as predefined criteria (German origin, audio track with spoken text, duration >1 min), videos were identified and transcribed into an anonymized text version.
Background And Objective: Multiple oral therapies are required long term for the majority of patients with type 2 diabetes mellitus to achieve acceptable glycaemic levels; alternatively, insulin therapy has to be initiated. This study investigated the addition of acarbose to maximum doses of sulfonylurea in very poorly controlled type 2 diabetes patients and assessed its effect in delaying further glycaemic deterioration.
Study Design: In this 78-week, double-blind, placebo-controlled European study, patients were randomised to receive acarbose, titrated to a maximum dose of 100mg three times daily, or matching placebo.